Invention Grant
- Patent Title: Predicting immunotherapy response in non-small cell lung cancer with serial radiomics
-
Application No.: US15853133Application Date: 2017-12-22
-
Publication No.: US10575774B2Publication Date: 2020-03-03
- Inventor: Anant Madabhushi , Yuanqi Xie , Vamsidhar Velcheti
- Applicant: Case Western Reserve University
- Applicant Address: US OH Cleveland
- Assignee: Case Western Reserve University
- Current Assignee: Case Western Reserve University
- Current Assignee Address: US OH Cleveland
- Agency: Eschweiler & Potashnik, LLC
- Main IPC: G06T7/11
- IPC: G06T7/11 ; G06T7/33 ; G06T7/00 ; G06K9/62 ; G16H30/40 ; A61B6/00 ; A61B5/02 ; G06T7/174 ; G16H50/30 ; G16H50/20 ; G16H50/50 ; A61K49/00 ; G06K9/46 ; A61B5/00 ; A61B6/03 ; A61B5/055

Abstract:
One embodiment include an image acquisition circuit that accesses a pre-treatment and a post-treatment image of a region of tissue demonstrating non-small cell lung cancer (NSCLC), a segmentation and registration circuit that annotates the tumor represented in the images, and that registers the pre-treatment image with the post-treatment image; a feature extraction circuit that selects a set of pre-treatment and a set of post-treatment radiomic features from the registered image; a delta radiomics circuit that generates a set of delta radiomic features by computing a difference between the set of post-treatment radiomic features and the set of pre-treatment radiomic features; and a classification circuit that generates a probability that the region of tissue will respond to immunotherapy based on the difference, and that classifies the region of tissue as a responder or non-responder. Embodiments may generate an immunotherapy treatment plan based, at least in part, on the classification.
Public/Granted literature
- US20180247410A1 PREDICTING IMMUNOTHERAPY RESPONSE IN NON-SMALL CELL LUNG CANCER WITH SERIAL RADIOMICS Public/Granted day:2018-08-30
Information query